Life Biosciences
Boston, United States · Biotechnology, Health Care, Other
Life Bio is a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. The company’s proprietary partial epigenetic reprogramming platform utilizes three transcription factors—Oct4, Sox2, and Klf4—to restore older and damaged cells to a younger state. This innovative approach targets a root cause of aging at the epigenetic level, thereby o
Key facts
- Headquarters
- Boston, United States
- Employees
- 24
- Industries
- Biotechnology, Health Care, Other
- Status
- Private
- Website
- lifebiosciences.com
- Company page
Recent activity at Life Biosciences
- : Life Biosciences has raised $80 million in Series D funding to advance its research and product development.
- : Life Biosciences
- : Life Biosciences Appoints Michael Ringel, Ph.D., J.D. as Chief Operating Officer
- : Life Biosciences, Leading Developer Of Therapeutics For Aging-Related Diseases, Completes $82 Million Series C Financing Round
- : Life Biosciences Receives Translational Research Funding From Alzheimer'S Drug Discovery Foundation
- : Life Biosciences LLC
- : Life Biosciences LLC
- : Life Biosciences LLC
- : Life Biosciences LLC
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Life Biosciences funding history
| Date | Round | Amount |
|---|---|---|
| Apr 2026 | Series D | $80.0M |
| Nov 2025 | Venture | $31.0M |
| Jan 2022 | Series C | $82.0M |
| Sep 2021 | Funding Round | Undisclosed |
| Sep 2020 | Venture | Undisclosed |
Leadership
- Yuan Yuan, Associate Director, Molecular Biology & Gene Delivery
- David Sinclair, Director, Promoter
- Ilan Stern, Director
- Bracken Darrell, Director
- Mehmood Khan, Executive Officer, Director
- Stuart Gibson, Director
Verified email and direct lines for Life Biosciences’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Life Biosciences files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Life Biosciences in the news
- Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER‑100 for Optic Neuropathies - Life Biosciences (Jun 09, 2026)
- Life Biosciences Announces First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies - Life Biosciences (Oct 08, 2026)
- Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026 - Life Biosciences (Oct 01, 2026)
- Life Biosciences Secures $80 Million Series D Financing - Life Biosciences (Apr 08, 2026)
- Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies - Life Biosciences (Jan 28, 2026)
- Optic Neuropathies and ER-100 - Life Biosciences (Apr 04, 2026)
- Life Biosciences Presents New Data at ARDD 2025 on the Company’s Partial Epigenetic Reprogramming Platform in Liver and Ocular Diseases - Life Biosciences (Aug 26, 2025)
- Pipeline - Life Biosciences (Dec 03, 2021)
Companies similar to Life Biosciences
- Nucleus Genomics · Biotechnology, Health Care, Other
- MED-X · Biotechnology, Health Care, Other
- CERo Therapeutics Holdings · Biotechnology, Health Care, Other
- Rgenta Therapeutics, Inc. · Biotechnology, Health Care, Other
- Mangoceuticals · Biotechnology, Health Care, Other
About Life Biosciences: questions and answers
What does Life Biosciences do?
Life Bio is a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. The company’s proprietary partial epigenetic reprogramming platform utilizes three transcription factors—Oct4, Sox2, and Klf4—to restore older and damaged cells to a younger state. This innovative approach targets a root cause of aging at the epigenetic level, thereby o
Where is Life Biosciences headquartered?
Life Biosciences is headquartered in Boston, United States.
How many employees does Life Biosciences have?
Life Biosciences has about 24 employees.
Has Life Biosciences raised funding?
Yes. Fundz has recorded 5 funding events for Life Biosciences. The most recent, Series D of $80.0M, was in Apr 2026.
What is the latest news on Life Biosciences?
On Apr 8, 2026, Life Biosciences has raised $80 million in Series D funding to advance its research and product development.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy